Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$229.35
-0.5%
$236.07
$211.43
$387.99
$6.24B0.93326,967 shs326,561 shs
Illumina, Inc. stock logo
ILMN
Illumina
$87.67
-0.4%
$78.19
$68.70
$156.66
$13.88B1.322.41 million shs1.47 million shs
Bio-Techne Co. stock logo
TECH
Bio-Techne
$51.58
+0.3%
$49.61
$46.01
$83.62
$8.08B1.381.40 million shs1.97 million shs
Waters Co. stock logo
WAT
Waters
$347.02
-0.8%
$341.09
$279.24
$423.56
$20.66B1.11473,666 shs286,718 shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
+2.00%+4.16%-3.54%-8.42%-19.01%
Illumina, Inc. stock logo
ILMN
Illumina
+3.53%+7.52%+16.13%+4.49%-19.89%
Bio-Techne Co. stock logo
TECH
Bio-Techne
+3.05%+5.37%+2.84%-14.67%-33.33%
Waters Co. stock logo
WAT
Waters
+0.38%+0.05%+1.79%-6.17%+16.06%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
4.6482 of 5 stars
3.42.00.04.22.52.52.5
Illumina, Inc. stock logo
ILMN
Illumina
4.9128 of 5 stars
4.25.00.04.22.53.31.3
Bio-Techne Co. stock logo
TECH
Bio-Techne
4.8806 of 5 stars
4.23.01.74.22.51.71.9
Waters Co. stock logo
WAT
Waters
4.0931 of 5 stars
3.33.00.03.51.91.71.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
2.75
Moderate Buy$324.2541.38% Upside
Illumina, Inc. stock logo
ILMN
Illumina
2.47
Hold$126.9444.79% Upside
Bio-Techne Co. stock logo
TECH
Bio-Techne
2.45
Hold$72.0039.60% Upside
Waters Co. stock logo
WAT
Waters
2.61
Moderate Buy$390.1912.44% Upside

Current Analyst Ratings Breakdown

Latest BIO, WAT, ILMN, and TECH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/11/2025
Illumina, Inc. stock logo
ILMN
Illumina
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$87.00 ➝ $99.00
6/9/2025
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$260.00 ➝ $245.00
6/5/2025
Bio-Techne Co. stock logo
TECH
Bio-Techne
Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$75.00
5/30/2025
Bio-Techne Co. stock logo
TECH
Bio-Techne
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$59.00
5/20/2025
Illumina, Inc. stock logo
ILMN
Illumina
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$105.00 ➝ $105.00
5/15/2025
Illumina, Inc. stock logo
ILMN
Illumina
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$190.00 ➝ $185.00
5/12/2025
Illumina, Inc. stock logo
ILMN
Illumina
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$136.00 ➝ $100.00
5/12/2025
Illumina, Inc. stock logo
ILMN
Illumina
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$92.00 ➝ $87.00
5/9/2025
Illumina, Inc. stock logo
ILMN
Illumina
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$120.00 ➝ $85.00
5/9/2025
Illumina, Inc. stock logo
ILMN
Illumina
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$122.00 ➝ $114.00
5/9/2025
Bio-Techne Co. stock logo
TECH
Bio-Techne
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$95.00 ➝ $70.00
(Data available from 6/11/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$2.54B2.46$8.51 per share26.95$234.52 per share0.98
Illumina, Inc. stock logo
ILMN
Illumina
$4.34B3.20$4.23 per share20.72$14.98 per share5.85
Bio-Techne Co. stock logo
TECH
Bio-Techne
$1.21B6.69$1.82 per share28.30$13.15 per share3.92
Waters Co. stock logo
WAT
Waters
$2.98B6.92$13.78 per share25.18$30.80 per share11.27
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
-$1.84B-$76.20N/A18.42N/A-71.86%3.90%2.76%7/30/2025 (Estimated)
Illumina, Inc. stock logo
ILMN
Illumina
-$1.22B-$6.07N/A16.991.60-27.95%13.37%5.49%8/5/2025 (Estimated)
Bio-Techne Co. stock logo
TECH
Bio-Techne
$168.10M$0.8252.0626.182.8813.22%12.73%9.75%8/6/2025 (Estimated)
Waters Co. stock logo
WAT
Waters
$637.83M$11.0232.4124.633.7921.56%46.31%15.67%7/30/2025 (Estimated)

Latest BIO, WAT, ILMN, and TECH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2025Q1 2025
Illumina, Inc. stock logo
ILMN
Illumina
$0.96$0.97+$0.01$0.82$1.03 billion$1.04 billion
5/7/2025Q3 2025
Bio-Techne Co. stock logo
TECH
Bio-Techne
$0.51$0.56+$0.05$0.14$317.92 million$316.18 million
5/6/2025Q1 2025
Waters Co. stock logo
WAT
Waters
$2.22$2.25+$0.03$2.03$655.50 million$661.71 million
5/1/2025Q1 2025
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$1.73$2.54+$0.81$2.29$573.01 million$585.40 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
N/AN/AN/AN/AN/A
Illumina, Inc. stock logo
ILMN
Illumina
N/AN/AN/AN/AN/A
Bio-Techne Co. stock logo
TECH
Bio-Techne
$0.320.62%N/A39.02%N/A
Waters Co. stock logo
WAT
Waters
N/AN/AN/AN/AN/A

Latest BIO, WAT, ILMN, and TECH Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/19/2025
Bio-Techne Co. stock logo
TECH
Bio-Techne
quarterly$0.080.67%5/19/20255/19/20255/30/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
0.18
6.48
4.85
Illumina, Inc. stock logo
ILMN
Illumina
0.63
1.77
1.42
Bio-Techne Co. stock logo
TECH
Bio-Techne
0.14
3.94
2.77
Waters Co. stock logo
WAT
Waters
1.14
0.94
0.65

Institutional Ownership

CompanyInstitutional Ownership
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
65.24%
Illumina, Inc. stock logo
ILMN
Illumina
89.42%
Bio-Techne Co. stock logo
TECH
Bio-Techne
98.95%
Waters Co. stock logo
WAT
Waters
94.01%

Insider Ownership

CompanyInsider Ownership
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
17.06%
Illumina, Inc. stock logo
ILMN
Illumina
2.60%
Bio-Techne Co. stock logo
TECH
Bio-Techne
3.90%
Waters Co. stock logo
WAT
Waters
0.82%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
8,20027.21 million23.11 millionOptionable
Illumina, Inc. stock logo
ILMN
Illumina
11,500158.30 million158.13 millionOptionable
Bio-Techne Co. stock logo
TECH
Bio-Techne
3,000156.77 million151.92 millionOptionable
Waters Co. stock logo
WAT
Waters
8,20059.51 million58.89 millionOptionable

Recent News About These Companies

Maxine Waters in downtown Los Angeles

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Bio-Rad Laboratories stock logo

Bio-Rad Laboratories NYSE:BIO

$229.35 -1.17 (-0.51%)
As of 03:34 PM Eastern

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Illumina stock logo

Illumina NASDAQ:ILMN

$87.67 -0.31 (-0.35%)
As of 03:55 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.

Bio-Techne stock logo

Bio-Techne NASDAQ:TECH

$51.58 +0.18 (+0.34%)
As of 03:55 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets in the United States, the United Kingdom, rest of Europe, Middle East, and Africa, Greater China, rest of Asia-Pacific, and internationally. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.

Waters stock logo

Waters NYSE:WAT

$347.02 -2.82 (-0.81%)
As of 03:55 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.